Drug Type Small molecule drug |
Synonyms Ephedirne Hydrichloride and Nitrofurazone Nasal Drops, Ephednne Hydrochloride Nasal Drops, Ephedrine Hyarochloride and Dipnenhydramine Hydrochloride + [22] |
Target |
Action agonists |
Mechanism adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Australia (03 Mar 2017), |
Regulation- |
Molecular FormulaC10H16ClNO |
InChIKeyBALXUFOVQVENIU-GNAZCLTHSA-N |
CAS Registry50-98-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypotension | Australia | 03 Mar 2017 | |
Asthma | - | - | - |
Nasal Obstruction | - | - | - |
Pulmonary Disease, Chronic Obstructive | - | - | - |
Phase 4 | 28 | niaycpwfrb(cosliatjwe) = gjrjljojaf mjvcvvvrwi (ziowyqjlss ) | - | 01 Apr 2020 | |||
Phase 2 | 53 | Saline Placebo (Saline Placebo) | cbsbbqhvgw(aiknguvmev) = mxgzjwqkbo mvnboqehyf (vdrcowmbxe, 0.26) View more | - | 22 May 2017 | ||
(IM Ephedrine) | cbsbbqhvgw(aiknguvmev) = goajpczybo mvnboqehyf (vdrcowmbxe, 0) View more | ||||||
Not Applicable | 90 | Caffeine/Ephedrine (CE) | dtdeqbrald(glhgmdwyiv) = gzjofkaaal tnblfolrry (zqcicomrqn ) View more | - | 01 Oct 2013 | ||
Leptin A-200 and Caffeine/Ephedrine (LCE) | embuvvvekx(rxizdxciil) = aucugitgjl akiiuoormg (gmvqdojhjh ) View more |